Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFirst Affiliated Hospital of Wannan Medical College

About this trial

What is this study about? We are studying whether the Pleth Variability Index (PVI)-a simple, non-invasive measurement from a pulse oximeter-can help predict low blood pressure (hypotension) during routine maintenance hemodialysis. Low blood pressure during dialysis is a common and potentially serious complication. Our goal is to find out if monitoring PVI can help identify patients at risk, so that early action can be taken.

Who can join? Adults aged 18 to 80 years. Patients who have been receiving maintenance hemodialysis regularly for more than 3 months.

Those who are willing and able to participate and sign an informed consent form.

Who cannot join? Patients with severe heart rhythm problems, severe peripheral circulation problems, or swelling that makes PVI measurement unreliable.

Patients who are pregnant or breastfeeding. Patients allergic to the dialysis filter or unable to cooperate with the study procedures.

What will happen during the study? PVI Measurement: Your PVI will be checked with a simple fingertip device before starting dialysis and again 30 minutes after dialysis begins.

Blood Pressure Monitoring: Your blood pressure will be closely watched throughout the dialysis session.

Data Collection: Information about your age, medical history, medications, lab results, dialysis settings, and other standard measurements will be recorded.

What are the benefits and risks? Benefits: By identifying patients at higher risk for low blood pressure during dialysis, the study may lead to safer and more comfortable dialysis treatment in the future.

Risks: All measurements used in this study are safe and non-invasive, with no extra risk compared to routine care.

Your Rights and Safety Participation is completely voluntary-you may leave the study at any time without affecting your medical care.

The study has been reviewed and approved by the hospital's ethics committee. Your privacy and personal data will be strictly protected.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 to 80 years.

Diagnosis of end-stage renal disease and undergoing maintenance hemodialysis for more than 3 months.

Able and willing to provide informed consent and comply with study procedures.

Disqualifiers

Severe cardiac arrhythmias or significant peripheral vascular disease that may interfere with PVI measurements.

Local edema, skin lesions, or other conditions that prevent accurate PVI monitoring.

History of hemodynamic instability unrelated to dialysis.

Pregnant or breastfeeding women.

Trial population

Adult patients aged 18 to 80 years with end-stage renal disease who have been receiving maintenance hemodialysis for more than three months at participating dialysis centers. Participants are required to be able to provide informed consent and cooperate with study procedures.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Non-invasive Monitoring

    Other intervention

    All participants will undergo non-invasive measurement of Pleth Variability Index (PVI) and routine blood pressure monitoring before and during hemodialysis sessions. No treatment or experimental intervention will be applied.

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Maintenance Hemodialysis Patients1 intervention

Trial outcomes

Primary outcomes

1

Predictive Value of PVI for Intradialytic Hypotension

PVI measured at baseline (pre-dialysis) and at 60 minutes after the start of hemodialysis. The sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve of PVI measured before and during hemodialysis in predicting hypotension events.

Time frame
Pre-dialysis (baseline), and 60 minutes after the start of a single hemodialysis session (total duration up to 4 hours).
2

Predictive Value of Percentage Change in Pleth Variability Index (%PVi) for Intradialytic Hypotension

The ability of the percentage change in PVI (%PVi) between pre-dialysis and 60minutes after the start of dialysis to predict intradialytic hypotension. This will be evaluated using sensitivity, specificity, and area under the ROC curve analysis.

Time frame
From pre-dialysis (baseline) to 60 minutes after the start of a single hemodialysis session (total duration up to 4 hours).

Secondary outcomes

1

Incidence of Intradialytic Hypotension

The proportion of hemodialysis treatments in which patients develop hypotension, defined as a decrease in systolic blood pressure of ≥20 mmHg

Time frame
Up to 1 dialysis session (4 hours)
2

Predictive Value of Change in Pleth Variability Index (dPVi) for Intradialytic Hypotension

The ability of the absolute difference in PVI (dPVi) between pre-dialysis and 60minutes after the start of dialysis to predict intradialytic hypotension. This will be evaluated using sensitivity, specificity, and area under the ROC curve analysis.

Time frame
From pre-dialysis (baseline) to 60 minutes after the start of a single hemodialysis session (total duration up to 4 hours).
3

Correlation Between PVI, dPVi, %PVi and Changes in Blood Pressure

Assessment of the statistical correlation between PVI parameters (PVI, dPVi, and %PVi) and changes in blood pressure, including systolic blood pressure, diastolic blood pressure, and mean arterial pressure, during the dialysis session. Blood pressure changes will be calculated as the difference between pre-dialysis (baseline) and corresponding post-initiation time points (60 minutes). Correlation analyses will use Pearson or Spearman methods as appropriate.

Time frame
Pre-dialysis (baseline) and 60 minutes after the start of a single hemodialysis session (total duration up to 4 hours).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

First Affiliated Hospital of Wannan Medical College

Lead sponsor

Wuhu City Second People's Hospital

Collaborator

Wuhu County Traditional Chinese Medicine Hospital

Collaborator